Selective Insurance Group, Inc.
SIGI News Today: Stay Updated with the Latest Selective Insurance Group, Inc. News in Real Time
Find SIGI news now at Meyka AI. Stay informed with the latest Selective Insurance Group, Inc. stocks updates, including price news, market analysis, and expert insights.
POW.TO Power Corporation (TSX) C$67.02 16 Mar 2026: earnings preview, model shows upside
POW.TO stock earnings preview for 16 Mar 2026. We review valuation, EPS, and Meyka AI forecasts for POW.TO stock
BEL.AX Bentley Capital (ASX) up 43.75% intraday 17 Mar 2026: drivers to watch
BEL.AX stock up 43.75% intraday to A$0.023 on 17 Mar 2026. Quick analysis, Meyka grade and forecast for ASX-listed Bentley Capital
March 17: Cuba Blackout Deepens Oil Sanctions Risk for Energy Markets
Cuba blackout raises oil sanctions risk. What it means for Australian fuel prices and ASX energy exposure. We map flows, scenarios, and investor actions to watch today.
William Blair Maintains Outperform on Bumble Inc. (BMBL) March 16, 2026
BMBL analyst rating: William Blair and Deutsche Bank maintained ratings on March 16, 2026; implications and Meyka grade B
JMT.LS Jerónimo Martins (EURONEXT) pre-market: results Mar 2026, margins key
Pre-market earnings preview for JMT.LS stock: Jerónimo Martins reports Mar 18, 2026; EPS, margins and Meyka forecast +4.26% upside.
Germany Special Fund March 17: 10% Investment Quota on Track, H2 Boost
Germany special fund set to activate as Berlin targets a 10% core-budget investment quota by 2026, with first impacts expected in H2 2026. What it means for infrastructure spending Germany, data hubs,
H.C. Wainwright Maintains Buy on Savara Inc. (SVRA) March 2026
H.C. Wainwright maintains Buy on Savara Inc.; SVRA analyst rating held ahead of August PDUFA
AirSculpt (AIRS) NASDAQ +51% after 12b-25 filing 16 Mar 2026: earnings Mar 20
AIRS stock jumps after AirSculpt files 12b-25; we preview Mar 20 earnings and Meyka AI outlook
Leerink Maintains Outperform on Spyre Therapeutics, Inc. (SYRE) March 16, 2026
Leerink maintains Outperform on Spyre; SYRE analyst rating stays positive on March 16, 2026